CLIENT: Barbara Davis Center for Diabetes (BDC),
University of Colorado School of Medicine
The Barbara Davis Center for Diabetes is one of the largest institutes in the world specializing in research and care for type 1 diabetes (T1D) across all age groups. The STOP T1D program, supported in part by Sanofi US, aims to educate health care providers on early detection and management of presymptomatic type 1 diabetes.
Key Insights:
The success of type 1 diabetes (T1D) management hinges on early detection, but many HCPs lack the tools and knowledge necessary for screening and monitoring presymptomatic T1D. The challenge was to create an accessible, engaging platform to address this gap while simultaneously driving awareness and participation. Furthermore, strategic digital marketing would be essential to ensure this important initiative reached a broad audience.
Positioning and Strategy:
The name STOP T1D (“Screen TO Prevent Type 1 Diabetes”) reflects the program's mission to halt the progression of T1D through early detection. Although we did not create the name, we strategically leveraged it in the program’s positioning, focusing on the urgency and significance of screening.
Partnership with Sanofi US:
A key element of this initiative is its support from Sanofi US, a prominent pharmaceutical company that has partnered with the Barbara Davis Center to ensure the success of the STOP T1D program. Sanofi's involvement brings crucial resources and added credibility, enhancing the program’s reach and impact in the healthcare community.
Design Approach:
We designed a modern, positive interpretation of a stop sign as the logo, emphasizing early intervention while conveying a welcoming and approachable tone. The program’s website offers a set of eleven modules covering topics from the pathophysiology of T1D to patient engagement and clinical trials. This online course offers health care providers Continuing Medical Education (CME) credits, incentivizing participation. To enhance engagement, the first module is freely accessible, giving visitors a preview of the full content upon registration.
Outcome:
The STOP T1D program, launched in June 2024, has rapidly gained traction among health care professionals. Its accessible design, comprehensive modules, and CME-accreditation have made it a vital resource for early screening and monitoring education. Through targeted digital marketing efforts, managed entirely by Get Stirred Up, the program continues to grow in both registrations and awareness. Supported in part by Sanofi US, the program is well-positioned to become a cornerstone in the national fight against delayed T1D diagnosis, ensuring that health care providers have the knowledge and tools they need to screen for this life-altering disease early.
